PharmAudio Guidelines – a new addition to PharmDev Innovations’ portfolio
Konstanz, March 19, 2014 – PharmDev Innovations, service provider for the international pharmaceuticals industry, is expanding its product portfolio with a new range of products launched as of February 2014. The first product in the PharmAudio series was an audiobook about EU GMP Annex 13 with comments in German language. Now the second product is available also about EU GMP Annex 13 with comments in English language.
(firmenpresse) - The pharma service provider PharmDev Innovations GmbH, which specialises in development and GMP, is expanding its portfolio to include a new product series. A new audiobook provides information about the EU GMP Annex 13 and is now available in the PharmAudio product series also with comments in English language.
Annex 13 regulates the requirements stipulated by GMP (Good Manufacturing Practice) for the preparation of investigational medicinal products. Many interfaces to GCP (Good Clinical Practice) the QP (Qualified Person) and to the entire supply chain have to be implemented professionally in the day-to-day operational environment. Implementing pharmaceutical regulatory guidelines is a complex matter. Reading these regulatory procedures and understanding and implementing them, not only requires time, but often also assistance.
The new PharmAudio series of audiobooks presents the current regulatory guidelines together with qualified comments based on many years of experience in the industry and from consulting. Dr Rango Dietrich explains the most important texts, centering his comments on over twenty years of experience in the pharma industry (also as a Qualified Person), helping the listener to understand the text quickly.
The new audiobook contains the original text of Annex 13 in English language with comments also in English and is available as Double-CD with Amazon or PharmAudio directly. The recommended retail price for this version is EUR 17.90 (excl. Postage and 19% VAT, respectively).
The audiobook is also available for download from the popular download platforms (iTunes, audible.de, Amazon, Google Play).
Additional audiobooks are currently in production and will soon be available for purchase.
Product Information
Understanding pharmaceutical regulatory guidelines
EU GMP ANNEX 13
Investigational medicinal products
Complexity meets Reality
Read by
Alison Rippier,
Dr Joseph Rippier and
Dr Rango Dietrich
Dr Rango Dietrich comments on the most important sections of the text, basing his annotations on over twenty years of experience in order to make them easier to understand.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
About PharmDev
PharmDev Innovations GmbH is a service provider for the international pharmaceutical industry with a special focus on development activities. Alongside comprehensive consulting expertise, the company offers a wide range of training concepts (open and in-house training sessions), web-based GMP training and now audiobooks from its own PharmAudio series to enable a better and faster understanding of the complex pharma regulatory guidelines.
PharmDev Innovations GmbH operates in Europe, Turkey, India and the USA providing services to pharma companies ranging from small start-ups to multinational organisations.
Please see www.pharmdev.info for further information.
Contact:
PharmDev Innovations GmbH
Dr. Rango Dietrich
Bleicherstr. 12
D-78467 Konstanz, Germany
+49 7531 9421919
info(at)pharmdev.de
Contact:
PharmDev Innovations GmbH
Dr. Rango Dietrich
Bleicherstr. 12
D-78467 Konstanz, Germany
+49 7531 9421919
info(at)pharmdev.de
Datum: 19.03.2014 - 08:33 Uhr
Sprache: Deutsch
News-ID 328810
Anzahl Zeichen: 2723
contact information:
Contact person: Josef Goetz
Town:
Konstanz
Phone: 0049-7732-919331
Kategorie:
Education Aids and Products
Typ of Press Release: Produktinformation
type of sending: Veröffentlichung
Diese Pressemitteilung wurde bisher 315 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"PharmAudio Guidelines – a new addition to PharmDev Innovations’ portfolio"
steht unter der journalistisch-redaktionellen Verantwortung von
PharmDev Innovations GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
